This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Services Email this article to a colleague Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Save to my personal folders Download to citation manager Rights & Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Smith, D. D. Articles by Schwarz, R. E. Search for Related Content PubMed PubMed Citation Articles by Smith, D. D. Articles by Schwarz, R. E. Social Bookmarking                            What's this?

Impact of Total Lymph Node Count on Staging and Survival After Gastrectomy for Gastric Cancer: Data From a Large US-Population Database

From the Division of Biostatistics, City of Hope Cancer Center, Duarte, CA; and Division of Surgical Oncology, Cancer Institute of New Jersey, New Brunswick, NJ

Address reprint requests to Roderich E. Schwarz, MD, PhD, Department of Surgery, University of Medicine and Dentistry of New Jersey, Robert Wood Johnson Medical School, Cancer Institute of New Jersey, 195 Little Albany St, New Brunswick, NJ 08901; e-mail: r.schwarz{at}umdnj.edu

BACKGROUND: Prognosis of potentially curable (M0), completely resected gastric cancer is primarily determined by pathologic T and N staging criteria. The optimal regional dissection extent during gastrectomy for gastric adenocarcinoma continues to be debated.

METHODS: A gastric cancer data set was created through structured queries to the Surveillance, Epidemiology, and End Results database (1973 to 1999). Relationships between the number of lymph nodes (LNs) examined and survival were analyzed for the stage subgroups T1/2N0, T1/2N1, T3N0, and T3N1.

RESULTS: In every stage subgroup, overall survival was highly dependent on the number of LNs examined. Multivariate prognostic variables in the T1/2N0M0 subgroup were number of LNs examined, age (for both, P < .0001), race (P = .0004), sex (P = .0006), and tumor size (P = .02). A linear trend for superior survival based on more LNs examined could be confirmed for all four stage subgroups. Baseline model–predicted 5-year survival with only one LN examined was 56% (T1/2N0), 35% (T1/2N1), 29% (T3N0), or 13% (T3N1). For every 10 extra LNs dissected, survival improved by 7.6% (T1/2N0), 5.7% (T1/2N1), 11% (T3N0), or 7% (T3N1). A cut-point analysis yielded the greatest survival difference at 10 LNs examined but continued to detect significantly superior survival differences for cut points at up to 40 LNs, always in favor of more LNs examined.

CONCLUSION: Although the impact of stage migration versus improved regional disease control cannot be separated on basis of the available information, the data provide support in favor of extended lymphadenectomy during potentially curative gastrectomy for gastric cancer.

Authors' disclosures of potential conflicts of interest are found at the end of this article.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Facebook    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				M. D. Duncan Proposal to Subclassify Stage IV Gastric Cancer Into IVA, IVB, and IVM--Invited Critique Arch Surg, January 1, 2009; 144(1): 45 - 45. [Full Text] [PDF]

				K. Y. Bilimoria, M. S. Talamonti, J. D. Wayne, J. S. Tomlinson, A. K. Stewart, D. P. Winchester, C. Y. Ko, and D. J. Bentrem Effect of Hospital Type and Volume on Lymph Node Evaluation for Gastric and Pancreatic Cancer Arch Surg, July 1, 2008; 143(7): 671 - 678. [Abstract] [Full Text] [PDF]

				C. Rizzetto, S.R. DeMeester, J.A. Hagen, C.G. Peyre, J.C. Lipham, and T.R. DeMeester En bloc esophagectomy reduces local recurrence and improves survival compared with transhiatal resection after neoadjuvant therapy for esophageal adenocarcinoma. J. Thorac. Cardiovasc. Surg., June 1, 2008; 135(6): 1228 - 1236. [Abstract] [Full Text] [PDF]

				W.-C. Liao, J.-T. Lin, C.-Y. Wu, S.-P. Huang, M.-T. Lin, A. S.-H. Wu, Y.-J. Huang, and M.-S. Wu Serum Interleukin-6 Level but not Genotype Predicts Survival after Resection in Stages II and III Gastric Carcinoma Clin. Cancer Res., January 15, 2008; 14(2): 428 - 434. [Abstract] [Full Text] [PDF]

				M. B. Slidell, D. C. Chang, J. L. Cameron, C. Wolfgang, J. M. Herman, R. D. Schulick, M. A. Choti, and T. M. Pawlik Impact of Total Lymph Node Count and Lymph Node Ratio on Staging and Survival after Pancreatectomy for Pancreatic Adenocarcinoma: A Large, Population-Based Analysis Ann. Surg. Oncol., January 1, 2008; 15(1): 165 - 174. [Abstract] [Full Text] [PDF]

				A. Le, D. Berger, M. Lau, and H. B. El-Serag Secular Trends in the Use, Quality, and Outcomes of Gastrectomy for Noncardia Gastric Cancer in the United States Ann. Surg. Oncol., September 1, 2007; 14(9): 2519 - 2527. [Abstract] [Full Text] [PDF]

				W. Hofstetter, A. M. Correa, N. Bekele, J. A. Ajani, A. Phan, R. R. Komaki, Z. Liao, D. Maru, T. T. Wu, R. J. Mehran, et al. Proposed Modification of Nodal Status in AJCC Esophageal Cancer Staging System Ann. Thorac. Surg., August 1, 2007; 84(2): 365 - 375. [Abstract] [Full Text] [PDF]

				J. S. Tomlinson, S. Jain, D. J. Bentrem, E. G. Sekeris, M. A. Maggard, O. J. Hines, H. A. Reber, and C. Y. Ko Accuracy of Staging Node-Negative Pancreas Cancer: A Potential Quality Measure Arch Surg, August 1, 2007; 142(8): 767 - 774. [Abstract] [Full Text] [PDF]

				F De Vita, F Giuliani, M Orditura, E Maiello, G Galizia, N Di Martino, F Montemurro, G Carteni, L Manzione, S Romito, et al. Adjuvant chemotherapy with epirubicin, leucovorin, 5-fluorouracil and etoposide regimen in resected gastric cancer patients: a randomized phase III trial by the Gruppo Oncologico Italia Meridionale (GOIM 9602 Study) Ann. Onc., August 1, 2007; 18(8): 1354 - 1358. [Abstract] [Full Text] [PDF]

				R. E. Schwarz and D. D. Smith Clinical impact of lymphadenectomy extent in resectable gastric cancer of advanced stage Ann. Surg. Oncol., February 1, 2007; 14(2): 317 - 328. [Abstract] [Full Text] [PDF]

				J O'Loughlin, E Dugas, K Maximova, and N Kishchuk Reporting of ethnicity in research on chronic disease: update Postgrad. Med. J., November 1, 2006; 82(973): 737 - 742. [Abstract] [Full Text] [PDF]

				R. E. Schwarz and D. D. Smith Extent of Lymph Node Retrieval and Pancreatic Cancer Survival: Information from a Large US Population Database Ann. Surg. Oncol., September 1, 2006; 13(9): 1189 - 1200. [Abstract] [Full Text] [PDF]